VEGF Human, His

Vascular Endothelial Growth Factor Human Recombinant, His

Recombinant Human Vascular Endothelial Growth Factor, produced in E. coli, is a non-glycosylated polypeptide chain (amino acids 207-371) comprising 185 amino acids. It has a molecular weight of 21.3 kDa, corresponding to Isoform L-VEGF165 (UniProt accession number P15692-11). This VEGF protein includes a 20 amino acid His-tag at the N-terminus and is purified using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT7614
Source
Escherichia Coli.
Appearance
A clear, sterile-filtered solution.

VEGI Human

Human Vascular Endothelial Growth Inhibitor Recombinant

Recombinant human TNFSF15, produced in E. coli, is a non-glycosylated polypeptide chain composed of 180 amino acids. With a molecular weight of 20.5 kDa, this purified protein is obtained through proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT8784
Source
Escherichia Coli.
Appearance
Sterile, lyophilized powder with a white appearance.

VEGI Human, His

Vascular Endothelial Growth InhibitorHuman Recombinant, His Tag

VEGI Human Recombinant, expressed in E. coli, is a non-glycosylated polypeptide chain containing 201 amino acids (72-251a.a.) with an N-terminal 21 amino acid His tag. This protein has a molecular mass of 22.7kDa. The purification process involves proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT8859
Source
Escherichia Coli.
Appearance
Sterile Filtered colorless solution.
Definition and Classification

Vascular Endothelial Growth Factor (VEGF) is a signal protein produced by many cells that stimulates the formation of blood vessels. It is a sub-family of growth factors, specifically the platelet-derived growth factor family of cystine-knot growth factors . The VEGF family in mammals comprises five members: VEGF-A, VEGF-B, VEGF-C, VEGF-D, and Placenta Growth Factor (PGF) . Additionally, VEGF-related proteins encoded by viruses (VEGF-E) and in the venom of some snakes (VEGF-F) have also been discovered .

Biological Properties

VEGF proteins are crucial signaling molecules involved in vasculogenesis (the formation of the embryonic circulatory system) and angiogenesis (the growth of blood vessels from pre-existing vasculature) . They are expressed in various tissues, particularly in vascularized tissues . VEGF is also involved in the formation of new blood vessels during embryonic development, after injury, and in muscles following exercise . The expression of VEGF is regulated by factors such as oxygen tension, cytokines, and differentiation .

Biological Functions

The primary function of VEGF is to promote the growth of new blood vessels. It plays a critical role in embryonic development, wound healing, and the formation of collateral circulation to bypass blocked vessels . VEGF is also involved in immune responses by being chemotactic for granulocytes and macrophages . It contributes to pathological conditions such as tumor growth and metastasis, as well as vascular diseases in the retina .

Modes of Action

VEGF exerts its effects by binding to tyrosine kinase receptors (VEGFRs) on the cell surface, leading to receptor dimerization and activation through transphosphorylation . The primary receptors for VEGF are VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) . These receptors activate downstream signaling cascades that promote endothelial cell proliferation, migration, and survival . VEGF also interacts with co-receptors such as neuropilins, which modulate its activity .

Regulatory Mechanisms

The expression and activity of VEGF are tightly regulated at multiple levels. Transcriptional regulation is influenced by oxygen levels, with hypoxia being a major inducer of VEGF gene transcription . Other regulatory factors include growth factors, hormones, and oncogenes . Post-translational modifications, such as phosphorylation, also play a role in modulating VEGF activity . Additionally, VEGF signaling is regulated by the availability of its receptors and the presence of co-receptors .

Applications

VEGF has significant applications in biomedical research, diagnostics, and therapeutics. In research, recombinant VEGF proteins are used to study angiogenesis and related signaling pathways . Clinically, VEGF inhibitors such as bevacizumab (Avastin) are used to treat cancers by inhibiting tumor angiogenesis . VEGF is also targeted in therapies for age-related macular degeneration and diabetic retinopathy . Diagnostic tools measuring VEGF levels can help in assessing disease progression and treatment efficacy .

Role in the Life Cycle

VEGF plays a vital role throughout the life cycle, from development to aging and disease. During embryogenesis, VEGF is essential for the formation of the vascular system . In adults, it is involved in physiological processes such as wound healing, menstrual cycles, and pregnancy . VEGF also contributes to pathological conditions, including cancer, retinopathy, and inflammatory diseases . Its role in promoting angiogenesis makes it a critical factor in both normal physiology and disease states .

© Copyright 2024 Thebiotek. All Rights Reserved.